针对胃肠道癌症中的铁和杯:分子机制,代谢脆弱性和治疗干预措施
Yang Zhang1,2,3, Yixiang Gu1,2,3, Ming Zhan4,5
1Department of Biliary-Pancreatic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
Molecular biomedicine
|November 7, 2025
概括
胃肠道癌症疗法可以通过向铁亡和亡,两个细胞死亡途径来改进. 它们的联合激活提供了对抗这些具有挑战性的恶性瘤的有希望的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞死亡途径 细胞死亡途径
背景情况:
- 胃肠道 (GI) 恶性瘤是一个重大的全球健康挑战,死亡率高,对标准治疗有抗性.
- 迫切需要针对细胞死亡机制的新型治疗策略.
- 铁 (依赖铁的脂质过氧化) 和铜 (由铜引起的蛋白质毒性压力) 是新兴的受调细胞死亡途径.
研究的目的:
- 系统地审查肠道恶性瘤中铁质和质之间的分子交叉.
- 评估联合激活这些途径在癌症治疗中的协同作用潜力.
- 讨论治疗干预措施,生物标志物和抵抗机制.
主要方法:
- 临床前和临床研究的系统审查.
- 分析连接铁和cuproptosis的分子机制.
- 评估治疗干预措施,包括小分子,纳米平台和免疫疗法.
主要成果:
- 铁和cuproptosis通过共享的代谢依赖和分子节点相互连接.
- 铁和cuproptosis的联合激活表明在肠道瘤中具有协同作用的抗癌潜力.
- 不同的治疗策略显示出利用这种联系的希望.
结论:
- 铁灭菌-灭菌联系代表了开发用于肠道癌症的新型协同疗法的有希望的途径.
- 对预测生物标志物和克服耐药性的进一步研究对于临床转化至关重要.
- 了解这种交叉语音可以导致更有效的治疗GI恶性瘤.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


